Can-Fite BioPharma Ltd. Deferred Revenue (Non-Current)
Can-Fite BioPharma Ltd. (CANF) had Deferred Revenue (Non-Current) of $1.90 million as of 2023-06-30, per its 6-K filed 2023-08-31.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueNoncurrent · last filed 2023-08-31
- 2023-06-30: Deferred Revenue, Noncurrent $1.90M.
- 2022-12-31: Deferred Revenue, Noncurrent $2.29M.
- 2022-06-30: Deferred Revenue, Noncurrent $2.66M.
- 2021-12-31: Deferred Revenue, Noncurrent $3.07M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2023-06-30 | $1.90M 6-K · filed 2023-08-31 |
| 2022-12-31 | $2.29M 6-K · filed 2023-08-31 |
| 2022-06-30 | $2.66M 6-K · filed 2022-08-25 |
| 2021-12-31 | $3.07M 20-F · filed 2023-03-30 |
| 2021-06-30 | $3.34M 6-K · filed 2021-08-26 |
| 2020-12-31 | $2.16M 20-F · filed 2022-03-24 |
| 2020-06-30 | $2.12M 6-K · filed 2020-08-27 |
| 2019-12-31 | $2.42M 20-F · filed 2021-03-25 |
| 2018-12-31 | $1.82M 6-K · filed 2020-06-01 |